Literature DB >> 786300

[The influence of pivmecillinam on the human gut flora (author's transl)].

H Knothe.   

Abstract

The effect of pivaloyloxymethyl ester of 6-beta-[(hexahydro-1H-azepin-1-yl)-methyleneamino]-penicillanic acid (pivmecillinam, FL 1039) on the gut flora of human subjects was investigated at different doses. Following administration of 1.2 g or 2.4 g/die E. coli and other enterobacteriaceae species were markedly reduced. The response of enterococci and bacteroides species showed no uniformity. No overgrowth of the gut flora by Pseudomonas, Staphylococci or Candida was observed. Meanwhile it has been possible to inspect stool specimens of a patient who was suffering from a septicaemic Salmonella infection and was treated with a combination of pivmecillinam-HCl 4 X 800 mg/pivampicillin-HCl 4 X 350 mg/die for one month. After disappearance of Salmonellae during therapy enterobacteriaceae decreased to amounts of 10(2)--10(4), all strains of which were highly susceptible to mecillinam.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 786300

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Growth properties of mecillinam-resistant bacterial variants in urine.

Authors:  J D Anderson; M A Adams; H M Webster; L Smith
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

2.  Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women.

Authors:  Karen Ejrnaes; Dorthe Sandvang; Bettina Lundgren; Sven Ferry; Stig Holm; Tor Monsen; Rolf Lundholm; Niels Frimodt-Moller
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

3.  Pharmacokinetic comparison of oral bacampicillin and parenteral ampicillin.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

4.  Pivmecillinam in the treatment of therapy resistant urinary tract infections. A comparison with pivmecillinam, pivampicillin and their combination.

Authors:  B T Andersen; M Joergensen; J Lorenzen
Journal:  Infection       Date:  1980       Impact factor: 3.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.